Skip to main content
Fig. 2 | Cancer Imaging

Fig. 2

From: Post-neoadjuvant treatment pancreatic cancer resectability and outcome prediction using CT, 18F-FDG PET/MRI and CA 19–9

Fig. 2

Flow diagram showing changes in CT resectability scores. Flow diagram shows changes in CT resectability scores of the three reviewers in consensus after review of post-neoadjuvant therapy PET/MRI (A) and PET imaging plus carbohydrate antigen 19–9 (B) and R0 resection rate of each score. Score 1, definitely unresectable; score 2, probably unresectable; score 3, indeterminate; score 4, probably resectable; score 5, definitely resectable. NAT, neoadjuvant therapy; PDAC, pancreatic ductal adenocarcinoma; PET, positron emission tomography; CA 19–9, carbohydrate antigen 19–9

Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us